May 30, 2019
F-star updates on FS118 Clinical Trial and Announces Presentation at ASCO 2019
Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT)…
Pharmaceuticals, Biotechnology and Life Sciences
Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT)…
Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT)…
DUBLIN–(BUSINESS WIRE)–The “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report has been added to…
DUBLIN–(BUSINESS WIRE)–The “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report has been added to…
Submission Follows Productive Pre-NDA Meeting and Marks On-time Execution of First of Two NDA Submissions Planned for 2019 CAMBRIDGE, Mass.–(BUSINESS…
DUBLIN–(BUSINESS WIRE)–The “Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes” report has been added to…
DUBLIN–(BUSINESS WIRE)–The “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018” report has been added to…
DUBLIN–(BUSINESS WIRE)–The “Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals” report has been added to…
SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging over-the-counter (“OTC”) consumer goods…
DUBLIN–(BUSINESS WIRE)–The “Cystic Fibrosis Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added…